RhFGF21, on the other hand, reduced neuroinflammation after cerebral ischemia by inhibiting NF-κB and upregulating PPARγ, thereby inhibiting M1 polarization and pro-inflammatory cytokine expression in microglia (Wang D. et al., 2020). Here, NFKB1 is linked to Cerebral ischemia.